EndoPredict(®) in early hormone receptor-positive, HER2-negative breast cancer
EndoPredict® 用于早期激素受体阳性、HER2 阴性乳腺癌
期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-020-05688-1
Almstedt, K; Mendoza, S; Otto, M; Battista, M J; Steetskamp, J; Heimes, A S; Krajnak, S; Poplawski, A; Gerhold-Ay, A; Hasenburg, A; Denkert, C; Schmidt, M